Copy number polymorphisms are not a common feature of innate immune genes  by Linzmeier, Rose M. & Ganz, Tomas
Genomics 88 (2006) 122–126
www.elsevier.com/locate/ygenoShort Communication
Copy number polymorphisms are not a common feature
of innate immune genes
Rose M. Linzmeier ⁎, Tomas Ganz
Departments of Medicine and Pathology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles,
CA 90095-1690, USA
Received 22 November 2005; accepted 6 March 2006
Available online 17 April 2006Abstract
Extensive copy number polymorphism was recently reported for innate immunity-related α-defensin genes DEFA1 and DEFA3 and β-defensin
genes DEFB4, DEFB103, and DEFB104. To establish whether such polymorphisms are a common feature of innate immune genes we used
quantitative real-time PCR to determine the copy numbers of seven genes whose products have important innate immune functions. The genes
encoding lysozyme, lactoferrin, cathelicidin antimicrobial peptide (hCAP18/LL-37), cathepsin G, bactericidal/permeability-increasing protein,
azurocidin (CAP37/heparin-binding protein), and neutrophil elastase were each found to be single copy per haploid genome. These findings, along
with the recent observation that defensin genes DEFA4, DEFA5, DEFA6, and DEFB1 are single copy, suggest that copy number polymorphisms
are not a common feature of the innate immune genome but are restricted to a small subset of innate immunity-related genes.
© 2006 Elsevier Inc. All rights reserved.Keywords: Real-time PCR; Copy number polymorphisms; Large-scale copy number variation; Host defenseApproximately 5–10% of the human genome consists of
low-copy repeats (LCRs) [1]. Recombination between LCRs in
regions containing duplicated DNA sequences can lead to the
expansion and deletion of surrounding chromatin [2]. System-
atic scans of the entire human genome for areas that are copy
number polymorphic (CNP) have been made using microarray
technology-based comparative genomic hybridization (CGH)
[3–5]. Among the large-scale copy number variations identified
in these studies, multiple sites associated with genetic diseases
and cancers were found. The methodology of CNP discovery
and the role CNPs play in creating phenotypic differences are
emerging areas of study [6,7].
Among genes involved in innate immunity, the copy
number variability of several defensin genes has been well
established. The DEFA1 and DEFA3 CNP and variable
presence of the DEFA3 gene was demonstrated using
quantitative Southern hybridization [8]. Using the multiplex
amplifiable probe hybridization (MAPH) technique the
DEFB4, DEB103, and DEFB104 genes were also found to⁎ Corresponding author. Fax: +1 310 206 8766.
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doi:10.1016/j.ygeno.2006.03.005be CNP [9]. These genes were carried on the same
approximately 240-kb repeating unit and so vary in concert
with copy number ranging from 2 to 12 per diploid genome
(PDG). Comparing the number of DEFB4 gene copies with
the amount of DEFB4 mRNA for seven lymphoblastoid cell
lines, a direct correlation was found between DEFB4 gene
copies and DEFB4 transcription levels. Also using MAPH,
the number of DEFA1 and DEFA3 gene copies was found to
range from 4 to 11 in a sample of 111 subjects [10]. The
DEFA3 allele was absent completely in 10% of these
subjects. In a previous study, we used real-time PCR to
quantify the number of DEFA1 and DEFA3 genes for 27
subjects and found that the combined number ranged from 5
to 14 copies PDG [11]. The DEFA3 allele was absent in 26%
of these subjects. The amount of defensin peptides HNP 1–3,
the products of the DEFA1 and DEFA3 genes, isolated from
circulating neutrophils was directly proportional to the
combined copy number of the DEFA1 and DEFA3 genes.
In the same study the number of DEFB4 and DEFB103 genes
ranged from 2 to 8 DPG. Although this has not yet been
specifically demonstrated for DEFB4 and DEFB103, it is
reasonable to expect that as observed for DEFA1 and DEFA3,
123R.M. Linzmeier, T. Ganz / Genomics 88 (2006) 122–126individuals with more gene copies produce higher amounts of
the encoded peptides.
Interestingly, we observed that the highly CNP DEFA1 and
DEFA3 genes are adjacent to defensin genes consistently found
in two copies PDG: the α-defensin genes DEFA4, DEFA5, and
DEFA6 and the β-defensin DEFB1 [11]. We also reported that
in the case of the α-defensins DEFA1 and DEFA3 the mutation
causing the single-nucleotide polymorphism that distinguishes
these genes likely preceded their independent copy number
polymorphisms, as the presence or absence of the DEFA3 allele
is not related to the total DEFA1/3 copy number. In one subject
the usually minor allele DEFA3 accounted for the majority of
the DEFA1/3 gene copies (subject 3, 9 copies of DEFA3 of 13
combined copy number for DEFA1/3 [11]). The size of the
DNA unit duplicated in the DEFA1/3 CNP is approximately
20 kb (NCBI human genome database), much smaller than the
approximately 240-kb repeating unit of the closely linked
β-defensin locus. Unequal crossing over between LCRs in
duplicated regions giving rise to gene families can also account
for CNPs [12,13]. While individual variability in resistance to
infectious diseases is readily observed, the causes of this
diversity in immune function are poorly understood. One
possible source for this variability is CNP. To investigate
directly the prevalence of copy number polymorphisms in genes
of the innate immune system, we selected seven genes for copyTable 1
Gene expression and gene product function of the innate immunity target genes and
Gene symbol Gene name Regulation of expression
LYZ Lysozyme Constitutive, upper GI
tract and Paneth cells;
may be inducible in
mouse macrophages [12]
and in skin [24,25]





colon [31]; IL-6, ASK1,
and vitamin D upregulated,
skin [32–34]













MPO Myeloperoxidase Constitutivenumber quantification by real-time PCR. We employ the same
population sample previously used to show copy number
polymorphism in defensin genes [11]. Each of the selected
innate immunity genes is a member of a gene family, a group of
genes with common structural and functional features thought
to have diverged from an ancestral gene. The products of the
selected innate immunity genes have been well characterized
and shown to have important roles in host defense. The genes
and some of their characteristics are listed in Table 1. Some of
these genes vary in the number of orthologs carried by different
species, as summarized below.
Lysozyme was the first recognized antimicrobial protein,
discovered by Alexander Fleming in 1922. Lysozyme is
abundantly expressed in numerous human tissues and secretions
[14]. The number of genes encoding lysozyme varies greatly
among mammals, with humans and pigs carrying 1 gene, mice
and camels 2, and cows and sheep 10 [15] Recently 3 human
lysozyme-related genes have been reported to be expressed at
high levels in the epididymis [16]. Lactoferrin is a member of
the iron-binding transferrin family, which in humans includes
serum transferrin and melanotransferrin [17]. The genes
encoding these proteins are closely linked, mapping to 3q21–
q23, 3q21, and 3q28–q29, respectively. Cathelicidin peptides
form a family recognized by their conserved N-terminal
prosequence. The adjacent C-terminal antimicrobial peptidethe MPO reference gene
Site(s) of expression Known functions of protein




A muramidase, antimicrobial in vitro
and in mouse models; enhances
phagocytosis and binds LPS [27]
PMN secondary granules,
glandular epithelial cells [29]
An iron-binding protein antimicrobial
against bacteria, fungi, and viruses
directly and by iron chelation;
binds LPS [30]
PMN secondary granules,
skin, respiratory epithelia, and
gastric epithelia [35]
Antimicrobial against gram– and
gram+bacteria, binds LPS,
chemotactic for PMN,
monocytes, and mast cells [36]
PMN primary granules A serine protease, antimicrobial
against bacteria [37] and fungi [38] and
remodels tissue at wound sites [39]
PMN primary granules,
mucosal epithelia, and tears
[42,43]
An LPS-binding protein antimicrobial
against gram– bacteria [44]
PMN primary granules An enzymatically inactive protease
homolog antimicrobial against
gram– bacteria, increases vascular
permeability, binds endotoxin,
and chemotactic for monocytes [45]
PMN primary granules,
GI tract [46]
A serine protease antimicrobial
against gram– bacteria; also regulates
leukocyte trafficking and remodels
connective tissue [46,47]
PMN primary granules Antimicrobial to bacteria and
fungi and inactivates neutrophil
elastase [48,49]
Table 2
Real-time PCR primer sets
Primer name Primer sequence Sequence Accession No. Primer position in sequence Location in gene
LYZ 1F ATAGCCGCTACTGGTGTAAT X14008 2342–2361 Exon 2
LYZ 1R CTTTCAAGGCTTTTTCATTT X14008 2489–2470 Exon 2
LYZ 2F AAATATTTTGTTTCCCCAAG X14008 5189–5208 Exon 4
LYZ 2R CCACAACCTTGAACATACTG X14008 5340–5321 Exon 4
LTF 1F AGCTCAAAGGTCAGAGTCAT U95626 142814–142833 Exon 6
LTF 1R TGATGGTTTCTCTTTTCACA U95626 142925–142944 Exon 6
LTF 2F AAAGGAAACACCTTCACCTA U95626 129984–130004 Exon 14
LTF 2R TATGAAAGCCCCACTAGTTT U95626 130133–130114 Exon 14
CAMP 1F CCCAGGATAACAAGAGATTT X96735 2758–2777 Exon 4
CAMP 1R GTAGGGCACACACTAGGACT X96735 2906–2887 Exon 4
CAMP 2F TTCAGTCTCACTTGTTTTGC X96735 2963–2982 Downstream
CAMP 2R CTACTGCCTTACCCTGTGTC X96735 3112–3091 Downstream
CTSG 1F ATAATTTGGCAGCATGTGT J04990 653–671 Intron 1
CTSG 1R CTTTTATCCTCATGGAGCTT J04990 802–783 Intron 1
CTSG 2F CAGACCTACCTCTTGCTTTT J04990 1739–1758 Exon 3
CTSG 2R ATGATGTCATTCTGGATGG J04990 1888–1870 Exon 3
BPI 1F TTCAATGCCAACAAATAAAG AL359555 36852–36871 Intron 1
BPI 1R GGCCAAATAGTAAACTGACC AL359555 37001–36982 Intron 1
BPI 2F GACCTTGCTTTCCTTTAGTG AL499625 6779–6798 Intron 9
BPI 2R CTGTTCTGTGGATGAAGCTA AL499625 6928–6909 Intron 9
AZU1 1F CTAGTCCCAGCTACTCAGGA M96326 2577–2597 Intron 3
AZU1 1R TGCTGTATTGTTTTTGGAAG M96326 2727–2708 Intron 3
AZU1 2F AGTTTGGTCTCGAACTCCT M96326 2929–2947 Intron 3
AZU1 2R GAAGTGTCAGCGACATTAAC M96326 3077–3058 Intron 3
ELA2 1F AACTGAGTCACGGAGAGTTT AC112706 3130–3149 Upstream
ELA2 1R AGCTGCATTTATTGAGCAC AC112706 3281–3261 Upstream
ELA2 2F CGTGAATTTATTTCATCCTCT AC112706 3060–3080 Upstream
ELA2 2R GTTCATATCCTGGTTCTGGT AC112706 3209–3188 Upstream
MPO F CCAGCCCAGAATATCCTTGG M17176 13–32 Exon 12
MPO R GGTGATGCCTGTGTTGTCG M17176 162–144 Exon 12
TBP F TGAGAAGATGGATGTTGAGTTG AL031259 76585–76564 Exon 8
TBP R AGATAGCAGCACGGTATGAG AL031259 76438–76457 Exon 8
Fig. 1. Copy numbers of a panel of innate immunity genes. Gene copy number
PDG is shown on the y axis for 30 donors, the target genes are identified on the x
axis. The median copy number for each gene is shown by a line within the
shaded boxes that demarcate the 25th and 75th percentiles. The 10th and 90th
percentiles are marked by error bars. Individual data points outside the 10th and
90th percentile are represented by filled circles. The horizontal background line
indicates the average gene copy number of 2 PDG.
124 R.M. Linzmeier, T. Ganz / Genomics 88 (2006) 122–126portions vary greatly in size and structure. While humans and
mice have a single cathelicidin gene, multiple different
cathelicidin antimicrobial peptides have been found in some
mammalian species [18]. Pigs carry 12, cattle 11, and sheep
8 different cathelicidin genes [18,19]. The genes encoding
bactericidal/permeability-increasing protein (BPI) and its func-
tional opposite lipopolysaccharide binding protein (LBP) are
adjacent to each other, at 20q11.23 [20]. Along with
phospholipid transfer protein, also encoded on chromosome
20, and cholesteryl ester transfer protein, the gene for which is
located on chromosome 16, BPI and LBP are part of a larger
family of lipid-binding proteins [21]. The innate immunity
genes clustered at 19p13.3, azurocidin, neutrophil elastase, and
proteinase 3, have diverged from an ancestral proteinase gene
after duplication and mutation [22]. Another member of the
granule protease family, cathepsin G, is encoded in a separate
serine protease cluster. The 4 protease genes of this cluster,
located at 14q11.2, encode neutrophil cathepsin G, lymphocyte
CGL-1 and 2 (also known as granzyme B and H), and mast cell
chymase [23]. The myeloperoxidase gene, used as a reference
gene in this study, is adjacent to the eosinophil peroxidase and
lactoperoxidase genes at 17q23.1. These genes share primary
sequence homology and similar gene organization and their
products have similar functional properties [24]. Through
duplication of an ancestral gene, followed by mutation, thehomologous genes have acquired new functions, giving rise to a
multigene family [12]. We considered the possibility that the
LCR DNA sequences that provide the means for the duplication
of an ancestral gene could also promote CNPs of the descendant
genes.
125R.M. Linzmeier, T. Ganz / Genomics 88 (2006) 122–126In this study we investigated the prevalence of CNPs in
innate immunity using real-time PCR [11]. To make a direct
comparison of target and reference genes, their amplification
efficiencies must be the same [7,11]. Careful selection of primer
sets is required to achieve nearly identical PCR efficiencies.
Primers were matched for annealing temperature, 54°C, and
amplicon size, 150 bp. Accuracy was improved by selecting two
primer sets for each target gene and by using two different
reference genes, myeloperoxidase and the TBP gene for the
TATA box binding protein. Each of the reference genes has no
known pseudogenes and is single copy per haploid genome.
The primers selected are listed in Table 2. Each DNA sample
was evaluated in a single PCR-assay run with all target and
reference gene primer sets. All PCR set-up and cycling
conditions, as well as the calculation of gene copy number,
were as described previously [11]. The DNA from 30 subjects
was obtained for this study, 24 individuals from the multiethnic
Coriell Cell Repository (Camden, NJ, USA) and 6 normal
donors as described [11] and with the approval of the UCLA
Human Subjects Protection Committee.
The mean copy number PDG and standard deviation (in
parentheses) for each target gene were lysozyme, 2.00 (0.10);
lactoferrin, 1.97 (0.16); cathelicidin antimicrobial peptide
(hCAP18/LL-37), 1.97 (0.13); cathepsin G, 1.98 (0.12);
bactericidal/permeability-increasing protein, 1.90 (0.15); azur-
ocidin (CAP37/heparin-binding protein), 1.96 (0.15); and
neutrophil elastase, 1.87 (0.11); distributions are shown in Fig.
1. The results of this study demonstrate that the target genes are all
single copy per chromosome, with no evidence of copy number
polymorphism. However, due to the sample size of 30 subjects,
the possibility that 5% or less of the population may have variant
copy number at any of these loci cannot be ruled out.We therefore
conclude that defensin gene CNP is an unusual evolutionary
development and that copy number variability is not a general
feature of human innate immunity genes. Evolutionary processes
that produced these families of closely related genes, such as
cathelicidins and lysozyme that are present in multiple nearly
identical copies in other species [15,18,19], do not necessarily
generate human CNP. The specific molecular evolutionary
mechanisms that generate CNP and maintain them in human
populations are of great interest but remain to be elucidated.
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